Lifevantage Corporation

LFVN Consumer Defensive Packaged Foods

Lifevantage Corporation’s revenue for fiscal 2026 (year ended June 2026) was $182.6 million, down 20.1% from fiscal 2025. In the quarter to June 2026, revenue fell 23.1%, EPS fell 37.5% and free cash flow grew 346.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.00 0.00 0.00%
Market cap
$75.5M
P/E
15.0×
Fwd P/E
25.6×
Dividend yield
3.17%
F-score
5/9
Altman Z
2.93
Beneish M
−2.48
Dividend safety
65/100
Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
Piotroski F-Score
5 7 8 7 6 5 7 7 9 5
P/E ratio
36.02 15.44 24.74 16.29 7.99 18.43 20.71 26.21 16.35 15.60
Altman Z-Score
2.92 4.01 6.41 7.45 3.72 2.54 2.85 2.74 4.68 2.93
P/S ratio
0.30 0.44 0.83 0.82 0.47 0.27 0.26 0.39 0.70 0.43
P/FCF ratio
11.74 10.82 12.64 12.53 8.53 9.33 16.32 8.22 15.88 12.52
Altman Z″-Score (non-manufacturers)
(4.78) (2.46) (1.67) 0.06 0.51 (1.00) (0.81) (2.93) (0.45) (1.63)
Beneish M-Score
(2.22) (2.97) (3.16) (3.03) (1.70) (2.60) (3.30) (2.42) (2.52) (2.48)
P/Operating CF
30.42 16.19 26.89 20.40 12.35 20.16 14.52 30.35 154.97 16.41
P/B ratio
4.14 4.04 6.90 5.73 2.81 1.78 1.58 3.01 4.63 2.33
Dividend Safety Score
— — — — — — — — — 65
Price to Tangible BV
4.53 4.25 7.16 5.89 2.87 1.81 1.60 3.05 4.66 2.60
EV/Sales
0.28 0.38 0.76 0.74 0.38 0.19 0.17 0.32 0.63 0.36
EV/EBITDA
9.16 6.62 14.71 8.32 3.55 3.58 4.58 8.13 9.29 7.43
EV/Operating CF
8.50 5.83 9.72 9.36 5.11 4.87 5.26 5.28 12.04 6.46
EV/FCF
10.95 9.45 11.63 11.26 6.86 6.46 10.73 6.76 14.17 10.60
Quick Ratio
0.59 0.81 0.84 0.99 1.08 0.98 1.20 0.90 0.89 0.95
Current Ratio
1.52 1.64 1.65 1.75 1.91 1.83 2.26 1.69 1.87 1.89
Net Debt/EBITDA
(0.66) (0.96) (1.48) (1.07) (0.99) (1.86) (2.76) (2.13) (1.31) (1.67)
Debt/Assets
16.44% 10.58% 2.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.51 0.25 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
4.15 4.22 4.25 4.08 3.20 2.76 3.12 3.17 3.46 2.72
Operating CF/Net income
4.10 2.30 2.39 1.59 1.26 2.55 2.69 4.15 1.21 2.02
Capex/Depreciation
(0.63) (3.43) (1.29) (0.52) (0.64) (0.47) (0.85) (0.63) (0.43) (1.27)
Interest Coverage
7.81 22.64 30.38 128.88 1,036.18 757.50 (21.51) (10.07) — —
ROE
12.77% 31.59% 30.23% 38.21% 36.81% 9.13% 7.68% 9.69% 32.34% 14.87%
ROA
3.35% 11.95% 13.96% 20.23% 18.74% 4.18% 3.71% 4.65% 14.83% 7.57%
ROIC
26.46% 60.26% 62.40% 86.96% 80.76% 41.80% 20.41% 29.74% 52.80% 20.42%
Return on Tangible Assets
10.50% 26.52% 30.80% 44.39% 37.95% 10.15% 7.52% 12.69% 32.81% 19.98%
Average Days of Receivables
4.11 4.52 5.33 4.09 6.57 9.00 3.17 5.95 6.28 8.75
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
81.00% 77.77% 78.85% 77.06% 74.66% 77.87% 77.67% 77.13% 75.03% 74.22%
Intangible Assets out of Total Assets
0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.06
Share Based Compensation of Revenue
1.33% 1.57% 2.45% 2.11% 0.92% 0.86% 1.49% 1.64% 2.50% 1.28%
Graham Net Nets
0.08 0.11 0.08 0.10 0.06 0.14 0.23 0.04 0.08 0.13
Graham Number
1.68 3.80 4.85 6.64 7.36 3.60 3.61 3.36 7.13 4.91
Earnings Yield
2.78% 6.48% 4.04% 6.14% 12.52% 5.43% 4.83% 3.82% 6.12% 6.41%
Free Cash Flow Yield
8.52% 9.24% 7.91% 7.98% 11.72% 10.72% 6.13% 12.16% 6.30% 7.99%
Revenue per Share
14.37 14.52 16.08 16.51 15.65 16.01 16.99 16.07 18.65 14.57
Operating CF per Share
0.48 0.95 1.27 1.30 1.16 0.62 0.54 0.98 0.97 0.82
Capex per Share
(0.08) (0.33) (0.18) (0.19) (0.27) (0.12) (0.24) (0.18) (0.11) (0.28)
Free Cash Flow per Share
0.40 0.62 1.09 1.11 0.89 0.50 0.30 0.80 0.86 0.53
Cash per Share
0.83 1.19 1.34 1.57 1.65 1.57 1.72 1.36 1.65 1.19
Shareholders Equity per Share
1.05 1.57 1.94 2.36 2.62 2.45 2.76 2.09 2.83 2.68
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.05 1.57 1.94 2.36 2.62 2.45 2.76 2.09 2.83 2.68
Free Cash Flow
5.54 8.61 15.28 15.65 12.54 6.43 3.77 9.95 10.51 6.67
Working Capital
12.19 15.13 16.99 18.85 22.86 21.23 24.68 15.34 23.68 18.07
Capital Expenditures
(1.05) (4.65) (2.51) (2.68) (3.73) (1.53) (3.06) (2.24) (1.37) (3.57)
Net Current Asset Value
4.82 9.74 15.11 18.25 6.13 7.77 12.81 3.34 13.58 9.78
EV/EBIT
12.61 7.49 17.61 11.09 4.72 5.12 8.44 14.86 11.72 10.85
Capex to Sales
0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.02
Price to Operating Income
13.51 8.58 19.13 12.33 5.87 7.40 12.83 18.09 13.14 12.82
Other line items
Depreciation/Fixed assets
0.54 0.21 0.27 0.72 0.52 0.34 0.39 0.46 0.51 0.38
Cash ROIC
16.58% 19.56% 32.19% 28.24% 20.90% 12.43% 6.70% 23.21% 19.17% 13.75%
Accounts Receivable Turnover
105.02 85.29 77.65 78.79 67.00 45.59 61.47 78.27 63.56 43.97
Accounts Payable Turnover
4.87 8.05 8.45 8.73 7.44 5.36 7.91 8.86 8.58 8.40
Inventory Turnover
1.61 2.31 2.77 2.75 2.54 2.34 2.67 2.66 2.51 2.22
Average Days of Payables
52.91 39.94 49.79 33.85 64.46 71.49 29.49 51.55 37.42 45.93
Days of Inventory on Hand
180.83 142.73 132.20 133.52 154.32 157.82 135.22 132.60 168.16 144.02
Average Receivables
1.90 2.38 2.91 2.96 3.29 4.53 3.47 2.56 3.60 4.15
Average Payables
6.87 4.33 4.50 4.35 5.13 7.10 5.48 4.68 5.23 4.88
Average Inventory
20.85 15.10 13.69 13.82 15.02 16.31 16.27 15.56 17.86 18.42
Average Assets
48.05 48.20 53.21 57.08 68.80 74.72 68.41 63.21 66.13 67.03
Average Common Equity
12.59 18.24 24.57 30.23 35.03 34.16 33.08 30.32 30.32 34.12

Fold the line items

Columns are period end dates